Immunome Can Take The Fight To Competitors With Varegacestat
Immunome's varegacestat is in a phase 3 trial in patients with desmoid tumors that should produce results in H2'25. Read why ...
AFP22h
Almirall at the JPMorgan Conference - Entering a New Era of Sustained Growth
Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare Conference to provide an update on its business strategy and outlook.
NerdWallet6h
J.P. Morgan Self-Directed Investing Review 2025: Pros, Cons and How It Compares
J.P. Morgan Self-Directed Investing charges no commissions and offers a highly integrated app, which makes it a solid choice for individuals who want to trade their own investments — especially ...
The American Journal of Managed Care12h
Oncology R&D Will Follow Divergent Paths, Experts Say at JPM Event
A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
Indiatimes7h
JP Power Share Price
Company has Lodha & Co. as its auditors. As on 31-12-2024, the company has a total of 685.35 Crore shares outstanding.JP Power Share Price Today is Rs. 15.73. On previous day, the JP Power Share Price ...